Elicio Therapeutics Inc. (ELTX)
NASDAQ · Healthcare
Elicio Therapeutics Inc. Net Income 2020–2022
Elicio Therapeutics Inc. annual/quarterly net income history and growth rate from 2020 to 2023. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Elicio Therapeutics Inc. net income for the quarter ending March 31, 2023 was -8.0 M, a 13.73% increase year-over-year.
- Elicio Therapeutics Inc. net income for the twelve months ending March 31, 2023 was -29.6 M, a 66.04% decrease year-over-year.
- Elicio Therapeutics Inc. annual net income for 2022 was -28.2 M, a 48.31% decrease from 2021.
- Elicio Therapeutics Inc. annual net income for 2021 was -54.6 M, a 31.87% decrease from 2020.
- Elicio Therapeutics Inc. annual net income for 2020 was -80.1 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Elicio Therapeutics Inc. Net Income — FAQ
Elicio Therapeutics Inc. (ELTX) net income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Elicio Therapeutics Inc.'s net income?
Elicio Therapeutics Inc. (ELTX) reported net income of -$28M for fiscal 2022.
Where can I see ELTX's net income history?
The chart and table above show Elicio Therapeutics Inc.'s net income by year and by quarter, including the growth rate.